Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case

Daniela Ampollini

Antitrust Chronicle, 2012, vol. 7

Abstract: The IAA could find for the existence of the abuse only by misconstruing the very essence of patent law. Daniela Ampollini (Trevisan & Cuonzo)

JEL-codes: G38 (search for similar items in EconPapers)
Date: 2012
References: Add references at CitEc
Citations Track citations by RSS feed

Downloads: (external link)
http://www.competitionpolicyinternational.com/look ... -pfizer-xalatan-case (application/pdf)
Requires login and subscription

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:cpi:atchrn:7.2.2012:i=7742

Access Statistics for this article

More articles in Antitrust Chronicle from Competition Policy International
Series data maintained by Lindsay McSweeney ().